简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-07-02 10:25 Swedish Match USA, Inc. Presents to U.S. Food and Drug Administration Advisory Committee to Renew Modified Risk Claim for General Snus
2024-07-01 16:50 TauRx Submits UK Marketing Authorisation Application for HMTM as a Treatment for Alzheimer’s Disease
2024-06-28 12:03 Medisca Opens New Pharmaceutical Repackaging Facility to Meet Global Demands in Personalized Medicine
2024-06-28 10:54 QPS Announces New Laboratory Services for Clinical Trials and Cell Therapy Development
2024-06-27 16:32 Takeda Announces New Assignments of Directors
2024-06-26 10:31 Kenvue Releases Inaugural Healthy Lives Mission Report
2024-06-26 09:37 RoslinCT Appoints Professor Sir Peter Mathieson and Alexander Vos as New Non-Executive Directors
2024-06-26 09:34 Technology Holdings advises Design + Industry, a leading MedTech Product Design and Engineering consultancy, on its strategic sale to Capgemini
2024-06-25 10:58 Merck Provides Update on Phase III TrilynX Study in Locally Advanced Head and Neck Cancer
2024-06-24 15:05 Takeda Announces Approval of LIVTENCITY® (maribavir) in Japan for Post-Transplant Cytomegalovirus (CMV) Infection/Disease That Is Refractory to Existing Anti-CMV Therapies
2024-06-24 11:26 Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia
2024-06-22 09:24 QPS Announces New Global Clinical Research Operations Leadership
2024-06-21 15:35 C3i Center Inc is First CDMO in Canada to Receive Approval for a Drug Establishment License to Commercially Produce Cell Therapy Drug Products
2024-06-20 09:38 Takeda Presents Long-Term Data from Phase 3 ADVANCE-CIDP 3 Clinical Trial of HYQVIA® in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) at PNS Annual Meeting
2024-06-19 13:08 Galderma Granted Key Manufacturing License Updates for New Biologics Capabilities at Its Center of Excellence
2024-06-19 09:33 Medidata Launches Clinical Data Studio, Leveraging AI to Modernize the Data Experience in Clinical Trials
2024-06-18 14:00 Carestream Secures Crucial Business Partner Agreement in Peru
2024-06-18 09:45 Takeda Announces Phase 3 Topline Results for Soticlestat (TAK-935) in Patients with Dravet Syndrome and Lennox-Gastaut Syndrome
2024-06-17 11:35 Kirin Holdings Commences Tender Offer To Make FANCL A Wholly-Owned Subsidiary
2024-06-17 10:09 Takeda Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)

Business Wire Weibo

Press Releases

Latest Releases